Literacy Capital (BOOK) has released its final results for the year to 31 December 2024. The private equity investment trust, which focuses on direct investments in smaller, privately owned UK businesses, reported a 1.5% decline in NAV per share over the year, closing at 492.8p. Including the impact of a post-period bolt-on acquisition by portfolio […]
JPMorgan Claverhouse Investment Trust (JCH) has reported annual results for the year ended 31 December 2024, delivering a solid net asset value (NAV) total return of 9.2% (with debt at fair value). While marginally behind that of its All-Share Index benchmark, which JCH says returned 9.4%, the portfolio performed in line with broader UK equity […]
Partners Group Private Equity (PEY) has released its annual results for the year ended 31 December 2024, showing a solid NAV total return of 11.4%, driven largely by value creation within its portfolio of 12.8%. PEY’s share price total return for the year was 10.0%, ending 2024 with the shares trading at a 29% discount […]
Henderson Smaller Companies (HSL) has announced that Neil Hermon, co-manager of its portfolio, is retiring from Janus Henderson Investors and the asset management industry on 30 September 2025. Neil’s retirement comes after 22 years as fund manager of HSL, and over 36 years in financial services. Indriatti van Hien, Neil’s co-manager on HSL, will continue […]
In QuotedData’s morning briefing 21 March 2025: M&G Credit Income (MGCI) has announced the results of its placing and WRAP retail offer, which have collectively raised gross proceeds of £6.3m. MGCI will issue a total of 6,647,969 new ordinary shares at a price of 95.13 pence per new ordinary share, representing a 1.0% premium to […]
Schroders Capital Global Innovation (INOV) has announced that its portfolio company Araris Biotech AG, has entered into an agreement to be acquired by Taiho Pharmaceutical Co. Ltd. for an upfront payment of US$400m, with the potential for additional milestone payments of up to US$740m. The transaction is expected to be completed in first half of 2025. […]
Pershing Square Holdings Ltd (PSH) has published its annual report for the year ended 31 December 2024. Despite a challenging macro and geopolitical backdrop, the closed-ended fund delivered a NAV total return of 10.2%, while the share price rose 8.3%, as the discount to NAV widened slightly from 29.6% to 31.2% over the year. In […]
Bellevue Healthcare (BBH) has published its annual results for the year ended 30 November 2024, during which it provided NAV and share price total returns of 11.1% and 13.7%, which compare against a return of 11.5% for the MSCI World Healthcare Index (all in sterling terms). BBH’s chair, Randeep Grewal, says that while it is […]
F&C (FCIT) has published its annual results for the year ended 31 December 2024. During the year, FCIT provided NAV and share price total returns of 21.0% and 16.9% respectively, which it says compares against a return of 19.3% for its All-World Index benchmark. FCIT’s discount widened over 2024 from 5.9% at the start of […]
Chelverton UK Dividend (SDV) has published a prospectus in relation to a placing for new 2031 ZDP shares along with recommended proposals for the reconstruction and winding-up of SDV 2025 ZDP Plc and a placing programme for its ordinary shares. SDV is proposing to issue up to 15m new zero-dividend preference shares in 2031 ZDPCo […]
